Ravi Salgia, M.D., Ph.D.
- Lung cancer
- Targeted therapies
- Prevention of toxicities
- Drug development
- Database development
- Mechanisms of metastases
- Value-based genomics
- Medical Oncology
- Lung cancer
- Thymic malignancies
- Bronchial carcinoids
- Molecular alterations in thoracic malignancies
- Thoracic malignancies
Prior to joining City of Hope, Dr. Salgia served as tenured professor of medicine, pathology and dermatology; director of the Thoracic Oncology Program and the Aerodigestive Tract Program Translational Research Lab in the section of hematology/oncology; vice chair for translational research in the department of medicine; and associate director for translational science at the University of Chicago Comprehensive Cancer Center in Chicago.
Dr. Salgia earned his undergraduate summa cum laude in mathematics, biology and chemistry, and then his medical doctorate and Ph.D. from Loyola University in Chicago, where he also completed fellowships in neurochemistry and physiology. He continued his postgraduate training with an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, followed by a fellowship in medical oncology at Dana-Farber Cancer Institute in Boston, during which time he also served as a clinical fellow at Harvard Medical School in Boston.
Board-certified in medical oncology, Dr. Salgia serves on various panels for the National Cancer Institute. He has consistently received research grants from the National Institutes of Health for his research work, and has been awarded several invention discoveries and patents related to his work. He is the co-chief editor for the Journal of Carcinogenesis. Dr. Salgia also serves on the editorial advisory board of four additional journals. He has authored over 375 peer-reviewed articles, reviews and editorials, one book and over 30 book chapters.
Dr. Salgia is frequently invited to present his work at national and international conferences and symposia, and is the recipient of several honors and awards including πμε National Competition in Mathematics, Richard V. Andree Award for “Volume of an n-Dimensional Unit Sphere”; 2016 Asclepius Award from the Bonnie J. Addario Lung Cancer Foundation; IACA Award for Outstanding Contributions to Oncology; served as member of NIH/NCI’s Tumor Progression and Metastasis Study Section; and CONC Study Section; and he is also a member of the Thoracic Malignancy Steering Committee of the NCI.
- 2016 to present - Professor and Chair, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
- 2016 to present - Associate Director for Clinical Sciences, City of Hope, Duarte, CA
- 2008 to 2015 - Professor of Medicine, Pathology and Dermatology, University of Chicago
- 2006 to 2010 - Co-director, Physician Scientist Development Program, Department of Medicine, University of Chicago
- 2003 to 2008 - Associate Professor of Medicine, Pathology and Dermatology, University of Chicago
- 1996 to 2003 - Assistant Professor of Medicine, Pathology and Dermatology, Harvard Medical School, Boston, MA
- 1996 to 2003 - Assistant Professor of Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
- 1997 to 2003 - Courtesy Staff Physician, Emerson Hospital, Concord, MA
- 1997 to 2003 - Associate Physician, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
- 2003 - Co-director, Human Tissue Research Center for Thoracic Malignancies, Department of Pathology, University of Chicago
- 2003 - Chair, Upper Aerodigestive Group, University of Chicago Comprehensive Cancer Center
- 1994 to 1996 - President and CEO, Foundation for Faces of Children, The Children's Hospital, Boston, MA
- 1993 to 1997 - Board of Directors, Foundation for Faces of Children, The Children's Hospital, Boston, MA
- 1993 to 1996 - Instructor in Medicine, Pathology and Dermatology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
- 1993 to 1996 - Assistant Physician, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
- 1987 - Loyola University School of Medicine, Chicago, M.D.
- 1985 - Loyola University School of Medicine, Chicago, Ph.D.
- 1981 - Loyola University, Chicago, B.A. in Chemistry, Summa Cum Laude
- 1981 - Loyola University, Chicago, B.S. in Mathematics and Biology, Summa Cum Laude
- 1990 to 1993 - Fellow in Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
- 1990 to 1993 - Clinical Fellow in Medicine, Harvard Medical School, Boston, MA
- 1990 to 1993 - Clinical Fellow in Medicine, Brigham and Women's Hospital
- 1988 to 1990 - Internal Medicine Resident, The Johns Hopkins Hospital, Baltimore, MD
- 1987 to 1988 - Intern, The Johns Hopkins Hospital, Baltimore, MD
He was the first to clone the focal adhesion protein paxillin and also localize the gene to 12q24. His laboratory also identified the gain-of-function mutations of paxillin in lung cancer, defined receptor tyrosine kinases and identified unique targets in lung cancer such as MET/RON and EPHB4 receptor tyrosine kinases.
December 07, 2017
June 02, 2017
- American Association for Advancement of Science
- International Association for the Study of Lung Cancer
- American Association for Cancer Research
- American Society of Clinical Oncology
- American Society of Hematology
- 2017, IACA Award for Outstanding Contributions to Oncology
- 2008 to present - Top Doctors in America
- 2005 to present - Best Doctors in America
- 2012 to 2015 - Chicago Magazine's Top Doctors
- 1992 to 1993 - Frei Fellowship in Medical Oncology, Dana-Farber Cancer Institute
- 1990 to 1991 - Dana-Farber Friends' Award in Oncology
- 1982 - Richard V. Andee Award, National Competition in Mathematics
- 1981 - Father Gerst Award in Mathematics, Loyola University
- 1977 to 1981 - Dean's List, Loyola University 1977 - Bausch and Lomb Award in Science, Loyola University
- 1977 - Language Award in Spanish, Loyola University